Related Experiment Videos
Can we prevent type 1 diabetes?
1Louisiana State University Health Sciences Center, New Orleans, USA.
Abstract:
Preliminary laboratory and clinical studies suggest that the clinical onset of type 1 diabetes can be delayed or prevented in high-risk individuals. The NIH sponsored Diabetes Prevention Trial Type 1 is currently underway to determine whether prevention is possible using insulin to alter the autoimmune process.
Insights
Type 1 diabetes prevention may be possible in high-risk individuals. The Diabetes Prevention Trial Type 1 is investigating if insulin can alter the autoimmune process to delay or prevent disease onset.
Area of Science:
- Immunology
- Endocrinology
- Clinical Trials
Background:
- Type 1 diabetes is an autoimmune disease.
- Early intervention may alter disease progression.
- High-risk individuals can be identified.
Purpose of the Study:
- To determine if type 1 diabetes can be prevented.
- To investigate insulin's role in altering autoimmunity.
- To assess the feasibility of delaying clinical onset.
Main Methods:
- Utilizing insulin to modulate the autoimmune process.
- Conducting clinical trials in high-risk populations.
- Monitoring for delayed or prevented disease onset.
Main Results:
- Preliminary studies show potential for delay or prevention.
- Ongoing trials are evaluating insulin's efficacy.
- Further results are pending from the Diabetes Prevention Trial Type 1.
Conclusions:
- Type 1 diabetes prevention is a promising area of research.
- Insulin therapy may offer a strategy for autoimmune disease modification.
- Clinical trials are crucial for validating prevention strategies.